284 related articles for article (PubMed ID: 28586063)
1. MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis.
Tian H; Chen S; Zhang C; Li M; Zheng H
Mol Med Rep; 2017 Aug; 16(2):1039-1046. PubMed ID: 28586063
[TBL] [Abstract][Full Text] [Related]
2. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
3. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.
Gong Z; Yang Q; Zeng Z; Zhang W; Li X; Zu X; Deng H; Chen P; Liao Q; Xiang B; Zhou M; Li X; Li Y; Xiong W; Li G
Tumour Biol; 2016 Mar; 37(3):3683-95. PubMed ID: 26462838
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
5. microRNA expression profiling of nasopharyngeal carcinoma.
Li T; Chen JX; Fu XP; Yang S; Zhang Z; Chen KhH; Li Y
Oncol Rep; 2011 May; 25(5):1353-63. PubMed ID: 21373758
[TBL] [Abstract][Full Text] [Related]
6. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
7. An Integrated Analysis of mRNAs and miRNAs Microarray Profiles to Screen miRNA Signatures Involved in Nasopharyngeal Carcinoma.
Liu L; Wang H; Yan C; Tao S
Technol Cancer Res Treat; 2020; 19():1533033820956998. PubMed ID: 32985354
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells.
Li XH; Qu JQ; Yi H; Zhang PF; Yi HM; Wan XX; He QY; Ye X; Yuan L; Zhu JF; Li JY; Xiao ZQ
PLoS One; 2014; 9(1):e87767. PubMed ID: 24498188
[TBL] [Abstract][Full Text] [Related]
9. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.
Luo Z; Zhang L; Li Z; Li X; Li G; Yu H; Jiang C; Dai Y; Guo X; Xiang J; Li G
BMC Med Genomics; 2012 Jan; 5():3. PubMed ID: 22260379
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing.
Wang F; Lu J; Peng X; Wang J; Liu X; Chen X; Jiang Y; Li X; Zhang B
J Exp Clin Cancer Res; 2016 Jan; 35():17. PubMed ID: 26795575
[TBL] [Abstract][Full Text] [Related]
11. Integrated miRNA-mRNA analysis of Epstein-Barr virus-positive nasopharyngeal carcinoma.
Zhu LH; Miao XT; Wang NY
Genet Mol Res; 2015 Jun; 14(2):6028-36. PubMed ID: 26125802
[TBL] [Abstract][Full Text] [Related]
12. Construction and Analysis of lncRNA-Mediated ceRNA Network in Nasopharyngeal Carcinoma Based on Weighted Correlation Network Analysis.
Zou Z; Liu S; Ha Y; Huang B
Biomed Res Int; 2020; 2020():1468980. PubMed ID: 33102573
[TBL] [Abstract][Full Text] [Related]
13. Candidate pathways and genes for nasopharyngeal carcinoma based on bioinformatics study.
Chen J; Yang R; Zhang W; Wang Y
Int J Clin Exp Pathol; 2015; 8(2):2026-32. PubMed ID: 25973099
[TBL] [Abstract][Full Text] [Related]
14. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
Wang Y; Zhao Q; Lan N; Wang S
Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
[TBL] [Abstract][Full Text] [Related]
15. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing.
Li G; Liu Y; Liu C; Su Z; Ren S; Wang Y; Deng T; Huang D; Tian Y; Qiu Y
BMC Cancer; 2016 Sep; 16(1):719. PubMed ID: 27599611
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
Wu L; Zheng K; Yan C; Pan X; Liu Y; Liu J; Wang F; Guo W; He X; Li J; Shen Y
BMC Cancer; 2019 Aug; 19(1):843. PubMed ID: 31455274
[TBL] [Abstract][Full Text] [Related]
18. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
[TBL] [Abstract][Full Text] [Related]
19. The four‑microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients.
Zhang S; Yue W; Xie Y; Liu L; Li S; Dang W; Xin S; Yang L; Zhai X; Cao P; Lu J
Oncol Rep; 2019 Nov; 42(5):1767-1780. PubMed ID: 31545473
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the differentially expressed microRNA profiles in nasopharyngeal carcinoma.
Luan J; Wang J; Su Q; Chen X; Jiang G; Xu X
Oncotarget; 2016 Mar; 7(9):10513-21. PubMed ID: 26824418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
